From: The Endocrine Society

To: Representatives Reed and DeGette

Sent: 27 October 2017

"...Rising insulin costs and changing formularies have created a challenging environment for endocrinologists to provide optimal care and for patients to access therapies to appropriately manage their diabetes. As you have noted, average insulin prices have nearly tripled over the past 15 years and patients are becoming increasingly exposed to these costs due to high deductible plans and coinsurance. We appreciate your thoughtfulness in addressing these issues and look forward to working with you as Congress moves forward in identifying solutions to these serious problems..."

Read the full letter...